Smart Biomanufacturing: next-generation biopharma processes

The race for smart biopharma processes is driven by the emergence of three trends: personalized drugs, often tailored the genome of the patient, as a new treatment option for both rare and widespread diseases; flexibility as a means to make plants smarter and adaptable and finally using digitalization to acquire a deep level of process understanding. The industry increasingly relies on small-scale…